Notice2023-17232
Foreign-Trade Zone (FTZ) 7; Authorization of Production Activity; AbbVie Ltd.; (Pharmaceutical Products); Barceloneta, Puerto Rico
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
August 11, 2023
Issuing agencies
Commerce DepartmentForeign-Trade Zones Board
Full Text
<html>
<head>
<title>Federal Register, Volume 88 Issue 154 (Friday, August 11, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 154 (Friday, August 11, 2023)]
[Notices]
[Page 54570]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-17232]
-----------------------------------------------------------------------
DEPARTMENT OF COMMERCE
Foreign-Trade Zones Board
[B-29-2023]
Foreign-Trade Zone (FTZ) 7; Authorization of Production Activity;
AbbVie Ltd.; (Pharmaceutical Products); Barceloneta, Puerto Rico
On April 10, 2023, AbbVie Ltd., submitted a notification of
proposed production activity to the FTZ Board for its facility within
Subzone 7I, in Barceloneta, Puerto Rico.
The notification was processed in accordance with the regulations
of the FTZ Board (15 CFR part 400), including notice in the Federal
Register inviting public comment (88 FR 24386, April 20, 2023). On
August 8, 2023, the applicant was notified of the FTZ Board's decision
that no further review of the activity is warranted at this time. The
production activity described in the notification was authorized,
subject to the FTZ Act and the FTZ Board's regulations, including
section 400.14.
Dated: August 8, 2023.
Elizabeth Whiteman,
Executive Secretary.
[FR Doc. 2023-17232 Filed 8-10-23; 8:45 am]
BILLING CODE 3510-DS-P
</pre></body>
</html>Indexed from Federal Register on August 11, 2023.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.